Amazon Inc. (NASDAQ: AMZN): A Stock that’s always a Better Buy

The e-commerce giant Amazon is a constantly rising company with a very tough potential. We can say this because, at the time of the coronavirus pandemic when so many companies incurred huge losses, this company continued to rise without fail. It is a stock that is perfectly suited for a long-term investment. It was amongst the best stocks even before the coronavirus pandemic began and during the pandemic, it rose fairly and faced hardly any declines. Amazon Prime: Rise in Subscriptions The price of the stock is however quite high but it is equally profit-giving as well. Amazon’s Amazon Prime subscriptions also increased this year because the cinema halls were closed due to the pandemic and the films were released via online platforms which gave a major boost to all the major online entertainment platforms. The increase in the number of subscriptions not only benefitted the earnings of Amazon but also the investors who invested in this company and received profits. Growth Rate and Statistics  If we consider the previous quarter, then the revenue growth rate of Amazon hastened by as much as 37%. Amazon also recently stepped into the pharmacy business which has added more fuel to its growth. If we talk about the growth in the case of the income per share, it has risen by 68%. In the case of the operating earnings, these have risen by 17%. Overall, as compared to the last year, i.e. 2019, Amazon has only grown despite the coronavirus pandemic which became…

Pfizer Stock: A Buy Now or Not?

The world is still struggling with the coronavirus pandemic and a vaccine is much required at this point. Pfizer’s vaccine has gained approval from the United States Food and Drug Administration (FDA) and some other countries are also approving the vaccine but still, the recent days have been the days of some ups and downs for Pfizer when it comes to the Stock Market sector. The stocks of this company fell low on some days. This has brought up the question, whether or not one should go for purchasing the stocks of Pfizer. Let us have a look at the latest statistical data of Pfizer Inc. and the company which is its partner in the Corona Virus vaccine, i.e., BioNTech SE – ADR: Pfizer Inc. (NYSE: PFE) Market Capital:  $228.561B Average Volume:  39,455,182 52 Week Range:  $26.45 - $43.08 Forward Dividend and Yield:  1.56 (3.79%) BioNTech SE – ADR (NASDAQ: BNTX) Market Capital:  $30.652B Average Volume:  3,634,690 52 Week Range:  $27.73 - $131.00 Forward Dividend and Yield:  N/A (N/A) Pfizer’s Effective Vaccine and other Reasons which make it a Buy Now Stock The vaccine that these two firms have jointly developed against the coronavirus is 95% effective against this infection and is formulated by the new messenger RNA, i.e. mRNA technique. In the previous time, hardly any vaccines have received approvals that were formulated using this same technology but this vaccine from Pfizer has made its way. The vaccine brought Pfizer into the limelight and since the past month when…

Removal of Shares of Four Chinese Firms from the NASDAQ Indexes

As per an order from the United States, restrictions are now imposed on the buying of four shares of Chinese manufacturing and construction firms. On Thursday, the S&P Index and the Dow Jones Industrial Average became the first Indices to state that they will remove the blacklisted shares from their indices, and on Friday, NASDAQ stated that it will eliminate the shares of these four companies from its indices. On 21st December 2020, NASDAQ will remove the shares of the following four companies from the NASDAQ Index: China Communications Construction Company Limited (CCCGY) 52 Week Range:  $9.65 - $17.08 Average Volume:  315 Market Capital:  $15.489B Forward Dividend & Yield:  0.66 (6.81%) Semiconductor Manufacturing International Corporation (SMICY) 52 Week Range:  $6.97 - $27.54 Average Volume:  67,126 Market Capital:  $21.903B Forward Dividend & Yield:  N/A (N/A) China Railway Construction Corporation Limited (CWYCF) 52 Week Range:  $0.0002 – $1.1600 Average Volume:  313 Market Capital:  $15.719B Forward Dividend & Yield:  0.03 (4.56%) CRRC Corporation Limited (CRRC) 52 Week Range:  $2.860 - $6.100 Average Volume:  20,367,785 Market Capital:  $169.089B Forward Dividend & Yield:  0.16 (5.72%) The Investors have been banned from buying any securities from the companies that are blacklisted owing to the fact that last month (21st November 2020) a White House executive order stated the same. As per President Donald Trump’s administration, these firms have a link with the military of China. From the side of China, the response to this news was not positive and the Foreign Ministry Spokeswoman Hua Chunying criticized…